Skip to main content
TipRanks
Go Ultimate75% OFF

Sotera Health (SHC) Net Revenue by Segment

197 Followers

Net Revenue by Segment

Sotera Health reported net revenue by segment of $324.89M in Q3 2026, up 1.1% from Q2 2026 and up 4.4% year over year. This is the highest value since 2021.

Breaks down Sotera's revenue by business line, revealing which segments drive sales growth and where demand is strongest or weakest. A concentrated revenue base increases dependence on a few markets, while diversified growth across segments signals resilience. Tracking segment revenue trends highlights areas of pricing power, volume gains, or contract wins that are likely to shape future earnings.

$0.00$50.00M$100.00M$150.00M$200.00M$250.00M$300.00MMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

Sterigenics is the clear growth engine—steady, accelerating top‑line and margin expansion driven by pricing and volume that underpins the raised outlook—while Nordion is a smaller, lumpy contributor whose outperformance reflects timing of Cobalt‑60 harvests and can reverse quarter‑to‑quarter. Nelson Labs is stable with low‑single‑digit growth and sequential margin recovery but still faces year‑over‑year cost pressure. Management’s increased CapEx and improving leverage support sustained capacity-driven growth, but FX volatility, inflationary costs and ongoing litigation are meaningful near‑term risks.

SHC Net Revenue by Segment

PeriodSterigenicsNordionNelson LabsTotal
Q3 2026Sep 30, 2026$209.31M$55.02M$60.56M$324.89M
Q2 2026Jun 30, 2026$211.57M$49.15M$60.66M$321.38M
Q1 2026Mar 31, 2026$186.13M$42.01M$51.90M$280.05M
Q4 2025Dec 31, 2025$198.41M$49.83M$55.20M$303.44M
Q3 2025Sep 30, 2025$192.84M$62.80M$55.66M$311.31M
Q2 2025Jun 30, 2025$194.84M$42.43M$57.07M$294.34M
Q1 2025Mar 31, 2025$169.68M$32.56M$52.28M$254.52M
Q4 2024Dec 31, 2024$179.43M$56.79M$53.98M$290.20M
Q3 2024Sep 30, 2024$175.57M$51.31M$58.58M$285.47M
Q2 2024Jun 30, 2024$176.35M$41.24M$59.00M$276.59M
Q1 2024Mar 31, 2024$166.50M$24.01M$57.67M$248.18M
Q4 2023Dec 31, 2023$172.20M$79.83M$58.21M$310.24M
Q3 2023Sep 30, 2023$168.35M$40.10M$54.73M$263.18M
Q2 2023Jun 30, 2023$166.59M$31.98M$56.72M$255.28M
Q1 2023Mar 31, 2023$160.00M$8.55M$52.04M$220.59M
Q4 2022Dec 31, 2022$161.67M$34.09M$55.83M$251.59M
Q3 2022Sep 30, 2022$157.72M$35.07M$55.91M$248.70M
Q2 2022Jun 30, 2022$157.79M$50.48M$58.37M$266.64M
Q1 2022Mar 31, 2022$149.46M$34.00M$53.29M$236.75M
Q4 2021Dec 31, 2021$150.18M$36.70M$54.37M$241.25M
Q3 2021Sep 30, 2021$145.31M$28.77M$52.08M$226.16M
Q2 2021Jun 30, 2021$145.18M$49.13M$57.61M$251.92M
Q1 2021Mar 31, 2021$131.15M$25.92M$55.08M$212.15M

Related KPIs